Importance of the host genetic background on immune responses to Helicobacter pylori infection and therapeutic vaccine efficacy

FEMS Immunology and Medical Microbiology

Volumn 31, Issue 1, 2001, Pages 41-46

  Kim, Jang Seong ^a   Chang, Ji Hoon ^a   Chung, Soo Il ^a   Yum, Jung Sun ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

Author keywords

Animal model; Helicobacter pylori; Helicobacter pylori vaccine; Host factor

Indexed keywords

BACTERIUM ANTIBODY; CHOLERA TOXIN; HELICOBACTER PYLORI VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERIUM; BACTERIUM COLONY; CELL LYSATE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOMODULATION; INBRED STRAIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STOMACH; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; IMMUNOTHERAPY, ACTIVE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TIME FACTORS;

EID: 0034891983     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(01)00240-1     Document Type: Article

References (30)

1. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
2. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
3. Treatment of Helicobacter pylori
4. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment
5. Helicobacter pylori reinfection with identical organism: Transmission by the patient's spouse
6. Therapeutic immunization against Helicobacter infection
7. Therapeutic immunization against Helicobacter mustelae infection in naturally infected ferrets
8. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
9. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection
10. A small animal model of human Helicobacter pylori active chronic gastritis
11. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
12. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces
13. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
14. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
15. Major virulence factors, VacA and CagA are commonly positive in Helicobacter pylori isolates in Japan
16. cagA and vacA status of Spanish Helicobacter pylori clinical isolates
17. Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains
18. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis
19. Helicobacter pylori-associated gastritis in mice is host and strain specific
20. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: Implications for human disease
21. Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection
22. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice
23. Helicobacter pylori infection: Genetic and environmental influences
24. Blood type and the risk of gastric disease
25. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
26. b antigens
27. Long-term follow-up of voluntary ingestion of Helicobacter pylori
28. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection
29. Quantitative difference in the T cell response of BALB/c and C57BL/6 mice to immunization with rUreB
30. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses